Founded in 2017, Empirico is a next-generation therapeutics company that leverages human genetics, data science, and advanced experimental approaches to discover and develop novel medicines. The company's proprietary Precision Insights Platform is designed to systematically identify and validate genetically-validated drug targets. Empirico's mission is to illuminate the path from genetic insights to life-changing therapies for patients with serious diseases.

Founded in

Switzerland